Featured News

  • FDA Approves First Treatment for COVID-19

    FDA Approves First Treatment for COVID-19

    Friday, October 23, 2020
    On Thursday, the Food and Drug Administration approved the antiviral drug remdesivir for patients with COVID-19 severe enough to require hospitalization. Remdesivir has been on the Emergency Use Authorization (EUA) list for COVID-19 patients since May 1, 2020. Read More News

News